Christian Kohler, MD
Psychiatry · Philadelphia, PANPI 1245260363
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $1,710 of the $1,710 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, E.r. Squibb & Sons, L.L.C..
Across 1 payment — averaging $1710.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$2K
Across 22 payments — averaging $7741.94 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boehringer Ingelheim$124K
- Janssen Research & Development, LLC$46K
What the payments were for
- Consulting fees$1,710100%
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 1 | $1,710 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- COBENFY$1,710
How this compares
$1,710 in reported general payments places this provider in the 80th percentile of 1,838 psychiatry providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clozapine | 48 | $8,742 |
| LamictalLamotrigine | 14 | $2,183 |
| Ziprasidone Hcl | 14 | $1,386 |
| Propranolol Hcl ErPropranolol Hcl | 13 | $590 |
| Topiramate | 15 | $297 |
| Clonazepam | 18 | $241 |
| Divalproex Sodium ErDivalproex Sodium | 11 | $163 |
| Metformin Hcl | 13 | $68 |
| Lorazepam | 13 | $51 |
| Lamotrigine | 13 | $44 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Philadelphia
- Daniel WeintraubPhiladelphia$647K
- Michael ThasePhiladelphia$396K
- Freddy AliPhiladelphia$107K
- Richard JaffePhiladelphia$101K
- Ramesh EluriPhiladelphia$85K
- John LaurielloPhiladelphia$62K
- Sidra GhafoorPhiladelphia$56K
- Maria OquendoPhiladelphia$50K
- David OslinPhiladelphia$30K
- Bianca PrevidiPhiladelphia$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.